Sensus Healthcare, Inc. (SRTS) vs TELA Bio, Inc. (TELA)

Sensus Healthcare, Inc. and TELA Bio, Inc. are both Medical Devices companies. TELA Bio, Inc. is the larger, with a market value of $57.3M against $47.9M — 1.2× the size. TELA Bio, Inc. grew revenue faster over the last twelve months: 6.09% against −53.4%. TELA Bio, Inc. has the higher net margin (−51.5% vs −88.5%) and the lower return on invested capital (−217.1% vs −38.2%). Across the 17 metrics below, TELA Bio, Inc. leads on 12 and Sensus Healthcare, Inc. on 5.

Valuation

Metric SRTS TELA Medical Devices median
P/E n/m n/m 22.18
P/S 2.76 0.91 2.70
P/B 1.31 n/m 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m n/m 11.78
EV/Sales 1.94 1.27 2.38
Earnings yield (31.97%) (61.11%) (8.22%)
Free cash flow yield (14.40%) (47.86%) (7.80%)

Profitability

Metric SRTS TELA Medical Devices median
Gross margin 36.39% 68.29% 56.01%
Operating margin (75.72%) (42.56%) (15.03%)
Net margin (88.45%) (51.53%) (20.40%)
Free cash flow margin (39.82%) (39.57%) (7.24%)
Return on equity (34.83%) 1,232.54% (15.32%)
Return on assets (30.94%) (64.71%) (19.72%)
Return on invested capital (38.22%) (217.11%) (10.33%)

Growth

Metric SRTS TELA Medical Devices median
Revenue growth (TTM) (53.39%) 6.09% 8.80%
EPS growth (last fiscal year) (214.63%) 37.59% —
Revenue growth, 5-year CAGR 23.47% 34.54% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SRTS TELA Medical Devices median
Debt to equity 0.00 (3.53) 0.07
Current ratio 8.71 2.99 2.50
Net debt to EBITDA 2.28 (0.15) 0.49

Dividend

Metric SRTS TELA Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric SRTS TELA Medical Devices median
Market cap 47.90m 57.33m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack